연구물
18건 검색
- 연구출판물 · 학술지 논문JCR Q2Bortezomib, doxorubicin, and dexamethasone combination therapy followed by thalidomide and dexamethasone consolidation as a salvage treatment for relapsed or refractory multiple myeloma: analysis of efficacy and safety
Lee, Sung SookSuh, CheolwonKim, Bong-Seog정주섭Joo, Young-Don외 15명
- 연구출판물 · 학술지 논문JCR Q3Scopus Q2Analysis of the Efficacy of Thalidomide Plus Dexamethasone-Based Regimens in Patients With Relapsed/Refractory Multiple Myeloma Who Received Prior Chemotherapy, Including Bortezomib and Lenalidomide: KMM-166 Study
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Benefits of additional cycles of bortezomib/thalidomide/dexamethasone (VTD) induction therapy compared to four cycles of VTD for newly diagnosed multiple myeloma
Lee, Yoo JinMoon, Joon HoSohn, Sang KyunKim, Seok JinJung, Sung-Hoon신호진외 9명
- 연구출판물 · 학술지 논문JCR Q2Scopus Q2Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed
Kim, Hye JinYoon, Sung-SooLee, Dong SoonSohn, Sang KyunEom, Hyeon Seok정주섭외 11명
- 연구출판물 · 학술지 논문JCR Q2Scopus Q3Real-World Comparison of Carfilzomib, Lenalidomide, and Dexamethasone Versus Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma: KMM2004 Study
- 연구출판물 · 학술지 논문Induction Treatment With Cyclophosphamide, Thalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma: A Phase II Study
- 연구출판물 · 학술지 논문JCR Q3Scopus Q2Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone
Lee, Ho SupKim, KihyunLee, Je-JungYoon, Sung-SooBang, Soo-Mee신호진외 18명
- 연구출판물 · 학술지 논문JCR Q3Scopus Q2Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma
Ng, Soo ChinMoon, Joon-HoPark, Sung SooKoh, YoungilLee, Ji Hyun신호진외 11명
- 연구출판물 · 학술지 논문JCR Q2Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean Multip
Eom, Hyeon-SeokKim, Yeo-Kyeoung정주섭Kim, KihyunKim, Hyo Jung외 9명
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study)
Lee, Ho SupKim, KihyunKim, Seok JinLee, Je-JungKim, Inho신호진외 11명
- 연구출판물 · 학술지 논문JCR Q4Scopus Q3Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma
Lee, Ji HyunKim, Sung-HyunKim, Hye RyeonMin, Chang-KiLee, Je-Jung신호진외 4명
- 연구출판물 · 학술지 논문JCR Q2Scopus Q2The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study)
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1A multicentre prospective phase II study of rituximab combined with bortezomib, lenalidomide and dexamethasone, followed by lenalidomide maintenance (R-VRD) in patients with Waldenström's macroglobulinaemia (KMM1803)
Jung, Sung-HoonKim, DajungLee, Je-JungKim, KihyunMin, Chang-Ki신호진외 8명
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Superior outcomes and high-risk features with carfilzomib, lenalidomide, and dexamethasone combination therapy for patients with relapsed and refractory multiple myeloma: results of the multicenter KMMWP2201 study
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR
Spencer, AndrewLentzsch, SuzanneWeisel, KatjaAvet-Loiseau, HervéMark, Tomer M.신호진외 31명
- 연구출판물 · 학술지 논문JCR Q4Scopus Q3Risk Stratification Model in Elderly Patients with Multiple Myeloma: Clinical Role of Magnetic Resonance Imaging Combined with International Staging System and Cytogenetic Abnormalities
- 연구출판물 · 학술지 논문JCR Q2Scopus Q2Cyclophosphamide-containing regimen (TCD) is superior to melphalan-containing regimen (MPT) in elderly multiple myeloma patients with renal impairment
- 연구출판물 · 학술지 논문JCR Q2Scopus Q3Early Response to Bortezomib Combined Chemotherapy Can Help Predict Survival in Patients with Multiple Myeloma Who Are Ineligible for Stem Cell Transplantation
Lee, Ho SupKim, Yang SooKim, KihyunKim, Jin SeokKim, Hyo Jung정주섭외 10명



로그인
홈
Researcher Page
ORCID
ISNI